Cargando…
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium
Coronavirus disease 2019 (COVID-19) predisposes patients to thrombotic and thromboembolic events, owing to excessive inflammation, endothelial cell activation and injury, platelet activation and hypercoagulability. Patients with COVID-19 have a prothrombotic or thrombophilic state, with elevations i...
Autores principales: | Gorog, Diana A., Storey, Robert F., Gurbel, Paul A., Tantry, Udaya S., Berger, Jeffrey S., Chan, Mark Y., Duerschmied, Daniel, Smyth, Susan S., Parker, William A. E., Ajjan, Ramzi A., Vilahur, Gemma, Badimon, Lina, Berg, Jurrien M. ten, Cate, Hugo ten, Peyvandi, Flora, Wang, Taia T., Becker, Richard C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757397/ https://www.ncbi.nlm.nih.gov/pubmed/35027697 http://dx.doi.org/10.1038/s41569-021-00665-7 |
Ejemplares similares
-
International COVID-19 thrombosis biomarkers colloquium: COVID-19 diagnostic tests
por: Gurbel, Paul A., et al.
Publicado: (2021) -
Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities
por: Davis, Karen D., et al.
Publicado: (2020) -
International COVID-19 biomarkers colloquium
por: Becker, Richard C., et al.
Publicado: (2021) -
SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disorders in severely ill patients with COVID-19 infection()
por: Llau, J.V., et al.
Publicado: (2020) -
Expert Consensus Statements on the Use of Corticosteroids in Non-severe COVID-19
por: Nasa, Prashant, et al.
Publicado: (2021)